We have located links that may give you full text access.
Prediction of clinically significant prostate cancer using multi parametric MRI, biparametric MRI and clinical parameters.
Urologia Internationalis 2024 August 31
INTRODUCTION: Multiparametric MRI (mpMRI) is gold standard for the primary diagnostic work-up of clinically significant prostate cancer (csPCa). The aim of this study was to assess the benefit of the perfusion sequence and the non-inferiority of an MRI without contrast administration (bpMRI) compared to mpMRI while taking clinical parameters into account.
METHODS: In this retrospective, non-interventional study we examined MRI data from 355 biopsy-naïve patients, performed on a 3T MRI system, evaluated by a board-certified radiologist with over 10 years of experience with subsequent mpMRI-TRUS fusion biopsy.
DISCUSSION: Only 16/355 (4.5%) patients benefited from DCE. In only 3/355 (0.8 %) patients csPCa would have been missed in bpMRI. BpMRI provided sensitivity and specificity (81.4 %; 79.4 %) comparable to mpMRI (75.2 %; 81.8 %). Additionally, bpMRI and mpMRI were independent predictors for the presence of csPCa, individually (OR 15.36; p < 0.001 vs. 12.15; p = 0.006) and after accounting for established influencing factors (OR 12.81; p < 0.001 vs. 6.50; p = 0.012). I When clinical parameters were considered, a more balanced diagnostic performance between sensitivity and specificity was found for mpMRI and bpMRI. Overall, PSA density showed the highest diagnostic performance (AUC = 0,81) for the detection of csPCa.
CONCLUSION: The premise of the study was confirmed. Therefore bpMRI should be adopted as soon as existing limitations have been lifted by prospective multi-reader studies.
METHODS: In this retrospective, non-interventional study we examined MRI data from 355 biopsy-naïve patients, performed on a 3T MRI system, evaluated by a board-certified radiologist with over 10 years of experience with subsequent mpMRI-TRUS fusion biopsy.
DISCUSSION: Only 16/355 (4.5%) patients benefited from DCE. In only 3/355 (0.8 %) patients csPCa would have been missed in bpMRI. BpMRI provided sensitivity and specificity (81.4 %; 79.4 %) comparable to mpMRI (75.2 %; 81.8 %). Additionally, bpMRI and mpMRI were independent predictors for the presence of csPCa, individually (OR 15.36; p < 0.001 vs. 12.15; p = 0.006) and after accounting for established influencing factors (OR 12.81; p < 0.001 vs. 6.50; p = 0.012). I When clinical parameters were considered, a more balanced diagnostic performance between sensitivity and specificity was found for mpMRI and bpMRI. Overall, PSA density showed the highest diagnostic performance (AUC = 0,81) for the detection of csPCa.
CONCLUSION: The premise of the study was confirmed. Therefore bpMRI should be adopted as soon as existing limitations have been lifted by prospective multi-reader studies.
Full text links
Related Resources
Trending Papers
Catastrophic Antiphospholipid Syndrome: A Review of Current Evidence and Future Management Practices.Curēus 2024 September
Oxygen therapy and noninvasive respiratory supports in acute hypoxemic respiratory failure: a narrative review.Annals of Intensive Care 2024 October 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app